128 filings
Page 4 of 7
8-K
3vucff mxsgy60
1 Sep 20
Sun BioPharma, Inc. Announces Pricing of $10.5 Million Public Offering and Uplisting to the Nasdaq Capital Market
4:12pm
8-K
yq02t5oojd3
11 Aug 20
Sun BioPharma, Inc. Provides Business Update and Reports Q2 2020 Financial Results
8:15am
8-K
kvbw623
16 Jul 20
Sun BioPharma, Inc. Appoints Jennifer K. Simpson, Ph.D., as President and CEO
8:02am
8-K
6azxm61mnyx0gzz8nz
30 Jun 20
Sun BioPharma, Inc. Receives FDA Fast Track Designation for SBP-101
4:16pm
8-K
ehhohigh ewu1w
19 Jun 20
Entry into a Material Definitive Agreement
8:00am
8-K
sjzlw
11 Jun 20
Entry into a Material Definitive Agreement
4:16pm
8-K
6pl9agnviryn1oexfy
26 May 20
Departure of Directors or Certain Officers
11:47am
8-K
b61l dvso
12 May 20
Sun BioPharma, Inc. Provides a Business Update and Reports Q1 2020 Financial Results
4:30pm
8-K
nx6k0mbvx6s9 hxm
3 Apr 20
Sun BioPharma Announces Pause in Enrollment of Clinical Trial of
4:47pm
8-K
dwq4 tw9f1
24 Mar 20
Sun BioPharma Provides Business Update and Reports Operating Results for FY2019
8:19am
8-K
wxw7hx9mm3jl8v8 d56i
28 Jan 20
Departure of Directors or Certain Officers
8:30am
8-K
dnp e3ubpip4521g0a
24 Jan 20
Sun BioPharma, Inc. Summarizes SBP-101 Phase 1 Clinical Data Presented at ASCO 2020 Annual Gastrointestinal Cancers Symposium
3:00pm
8-K
3xy2yl4psmnzzgc57
20 Dec 19
Departure of Directors or Certain Officers
9:00am
8-K
gt33ed
13 Nov 19
Sun BioPharma, Inc. Provides a Business Update and Reports Q3 2019 Financial Results
8:15am
8-K
vhs8maon
9 Oct 19
Entry into a Material Definitive Agreement
4:15pm
8-K
tvmh2c4h20njgkul
25 Sep 19
Entry into a Material Definitive Agreement
9:30am
8-K
50mikn xc8b82p
6 Sep 19
Entry into a Material Definitive Agreement
4:17pm
8-K
ysvad9xpk4b
29 Aug 19
Entry into a Material Definitive Agreement
5:03pm
8-K
dcwh715ce9r
13 Aug 19
Sun BioPharma, Inc. Provides a Business Update and Files Report for Q2 2019
7:32am
8-K
2oyil5
22 Jul 19
Sun BioPharma, Inc. Provides an Update on Ongoing
8:15am